$62.53 +2.20 (%) Merck & Co Inc - New York Stock Exchange, Inc.

Jan. 20, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Dow Industrials Take Lead As Trump Sworn In; Nvidia Sits Out Chip Rally

    Investors Business Daily | Jan. 20, 2017 | 16:03PM EST
  2. Stocks Fall Off Highs; Trump Sworn In As President

    Investors Business Daily | Jan. 20, 2017 | 13:31PM EST
  3. Amgen Could Gouge 'Top Pick' AbbVie With Humira Biosimilar: Jefferies

    Investors Business Daily | Jan. 20, 2017 | 12:57PM EST
  4. Bristol-Myers Slides After Another Lung Cancer Drug Setback

    TalkMarkets | Jan. 20, 2017 | 12:07PM EST
  5. Incyte Poised To Outperform Biotech Industry On Strong Pipeline

    Investors Business Daily | Jan. 20, 2017 | 11:00AM EST
  6. Stocks Up Nicely In Early Trade; Apple Shrugs Off China Trade Talk

    Investors Business Daily | Jan. 20, 2017 | 10:29AM EST
  7. Stock Futures Steer Higher; Merck, Skyworks, Emerge Energy Climb

    Investors Business Daily | Jan. 20, 2017 | 08:06AM EST
  8. Bristol-Myers Won't Seek Accelerated Opdivo Lung Cancer OK

    Investors Business Daily | Jan. 19, 2017 | 20:59PM EST
  9. Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst

    Investors Business Daily | Jan. 19, 2017 | 16:41PM EST
  10. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily | Jan. 19, 2017 | 16:34PM EST
  11. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily | Jan. 19, 2017 | 13:06PM EST
  12. FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    Investors Business Daily | Jan. 17, 2017 | 14:21PM EST
  13. Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy

    TalkMarkets | Jan. 14, 2017 | 12:58PM EST
  14. Week In Review: China's Sanpower Pays $820M For Provenge, A Prostate Immunotherapy

    TalkMarkets | Jan. 14, 2017 | 12:58PM EST
  15. Merck Carries Incyte On Keytruda Coattails In 4 'Hot' Tumors: Leerink

    Investors Business Daily | Jan. 13, 2017 | 12:52PM EST
  16. Stocks Get Defensive; Fiat Slumps, But Amazon A Bright Spot In Tech

    Investors Business Daily | Jan. 12, 2017 | 14:59PM EST
  17. Analysts See Merck Rally Continuing After Lung Cancer Drug News

    TalkMarkets | Jan. 12, 2017 | 14:31PM EST
  18. Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva

    Investors Business Daily | Jan. 12, 2017 | 14:00PM EST
  19. Stocks Stuck In Red; Apple, Disney Weigh On Dow; Nvidia Extends Slide

    Investors Business Daily | Jan. 12, 2017 | 13:46PM EST
  20. Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst

    Investors Business Daily | Jan. 12, 2017 | 11:14AM EST
  21. Markets Sound The Retreat In Early Trading; Merck 'New Best Idea'

    Investors Business Daily | Jan. 12, 2017 | 10:12AM EST
  22. Stock Futures Slip, Dollar Slides As Market Awaits Fed Comments

    Investors Business Daily | Jan. 12, 2017 | 08:01AM EST
  23. Trump Talks; Biotechs, Lockheed Fall; Merck Buoys Dow, Microchip Up

    Investors Business Daily | Jan. 11, 2017 | 15:00PM EST
  24. Trump Shoots Down Biotechs, Lockheed; Apple, Nvidia Weigh On Nasdaq

    Investors Business Daily | Jan. 11, 2017 | 13:41PM EST
  25. Merck Lung-Cancer Drug May Get OK For Large Patient Population

    Investors Business Daily | Jan. 11, 2017 | 12:28PM EST
  26. Bristol-Myers slips after FDA gives Merck lung cancer therapy priority review

    TalkMarkets | Jan. 11, 2017 | 11:50AM EST
  27. Markets Calm Ahead Of Trump Press Conference; HealthEquity In Buy Zone

    Investors Business Daily | Jan. 11, 2017 | 10:18AM EST
  28. Morning Call For Wednesday, Jan. 11

    TalkMarkets | Jan. 11, 2017 | 08:35AM EST
  29. NewLink pops after Incyte and Merck announce IDO inhibitor pact

    TalkMarkets | Jan. 9, 2017 | 14:37PM EST
  30. Stocks Still Mixed, Medicals Lead Upside; Is Incyte The Next Amgen?

    Investors Business Daily | Jan. 9, 2017 | 13:43PM EST
  31. Incyte Stock Breaks Out, It And Partner Merck Will Advance Key Trial

    Investors Business Daily | Jan. 9, 2017 | 12:14PM EST
  32. Mr. Market And A Valuation Of The Dow For Value Investors – January 2017

    TalkMarkets | Jan. 9, 2017 | 11:09AM EST
  33. Playing With The Dogs Of The Dow

    TalkMarkets | Jan. 9, 2017 | 10:30AM EST
  34. Here's A List Of The Most Crowded Trades On Wall Street

    TalkMarkets | Jan. 6, 2017 | 08:45AM EST
  35. Shining A Spotlight On Ailing Health Care ETFs

    TalkMarkets | Jan. 5, 2017 | 05:02AM EST
  36. Indexes Score Decent Gains As Disney Tries For Breakout; Oil Reverses

    Investors Business Daily | Jan. 3, 2017 | 16:21PM EST
  37. Merck (MRK) Does Well In 2016: Reasons For Outperformance

    TalkMarkets | Jan. 1, 2017 | 18:09PM EST
  38. The "Dogs Of The Dow" Investment Strategy Continues To Beat The Market & It's So Easy To Implement!

    TalkMarkets | Dec. 30, 2016 | 12:17PM EST
  39. Cempra Plunges To 52-Week Low, Shire Drug Label Expanded

    TalkMarkets | Dec. 30, 2016 | 10:33AM EST
  40. NewLink Jumps After Report Of Ebola Vaccine Efficacy

    TalkMarkets | Dec. 23, 2016 | 15:54PM EST
  41. J&J Back In Talks With Actelion, Teva Settles Corruption Probe

    TalkMarkets | Dec. 23, 2016 | 13:37PM EST
  42. Biogen Likely To Trim EPS View On Hemophilia Spinoff, Floundering MS Unit

    Investors Business Daily | Dec. 21, 2016 | 16:17PM EST
  43. Biogen Likely To Trim EPS View On Hemophilia Spinoff, Floundering MS Unit

    Investors Business Daily | Dec. 21, 2016 | 12:55PM EST
  44. Biogen Takeout Still Possible After Internal Promotion For CEO: RBC

    Investors Business Daily | Dec. 20, 2016 | 13:05PM EST
  45. Bristol-Myers Will Gain In Lung Cancer Square-Off Vs. Merck: Jefferies

    Investors Business Daily | Dec. 19, 2016 | 14:25PM EST
  46. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  47. Wiz Dogs: Do You Buy?

    TalkMarkets | Dec. 17, 2016 | 08:36AM EST
  48. Stocks Mixed, Mostly Unchanged; Apple Unfazed By Piper Jaffray Note

    Investors Business Daily | Dec. 16, 2016 | 12:09PM EST
  49. Morning Call For Friday, Dec. 16

    TalkMarkets | Dec. 16, 2016 | 09:47AM EST
  50. The FDA: Small-Cap Catalyst Or Small-Cap Killer?

    TalkMarkets | Dec. 16, 2016 | 09:37AM EST
Trading Center